IL-1β is a prominent tumorigenic inflammatory marker that can trigger a cascade of inflammatory mediators, and extensive preclinical data are available to support the role of IL-1β in various stages of cancer development and progression, including tumor initiation, promotion, angiogenesis, and metastasis [41–43]. Here, IL1B is linked to neoplasm.